A new study published in Clinical Therapeutics has once again shown the positive impact made by pharmacist interventions during diabetes clinical trials.
Echoing findings in another recently published BMJ article (PD 27 Mar 2017), in this case a research organisation employing clinical trial research pharmacists to communicate with patients performed a retrospective descriptive analysis of 12 clinical trials that involved two non-insulin glucose-lowering medications.
The study demonstrated across some 25,829 communications that pharmacists were able to identify, support, and address multiple types of interventions related to medication management during the clinical trials, including those related to concurrent medication use, adverse events, and other medication-related issues.
"These pharmacist interventions can result in better patient outcomes and, ultimately, more reliable study results for review and approval by regulatory agencies," the authors said - ncbi.nlm.nih.gov.
The above article was sent to subscribers in Pharmacy Daily's issue from 26 Jun 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 26 Jun 17